scholarly journals Synthesis, Characterization, Electrochemistry, and Spectroscopic Properties of Some Anthracenyl Functionalized Phthalocyanine Complexes of Ruthenium(II)

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Adewale O. Adeloye ◽  
Peter A. Ajibade

The synthesis of single- and double-decked anthracenyl functionalized ruthenium(II) phthalocyanine complexes has been achieved through a controlled electrophilic aromatic substitution reaction of the free unsubstituted ruthenium(II) phthalocyanine with preformed 9-bromo-10-(2,3-dimethylacrylic acid)-anthracene and/or 9-bromo-10-(2,3-dimethylacrylic acid)-dianthracene using 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) as catalyst. The complexes were characterized by IR, UV-Vis, fluorescence,1H,13C NMR, and elemental analyses. A dimeric complex (C3R′′RuPc, whereR′′is 9-dianthracenyl-10-(2,3-dimethylacrylic acid), obtained as the major product of the dianthracenyl-substituted ruthenium phthalocyanine complex displays a strong near-infrared visible absorption band wavelength maxima at 1027 nm (ε=5.47×103 M−1 cm−1), with an interesting photoluminescent and electroredox active properties.

2020 ◽  
Vol 17 ◽  
Author(s):  
W. Abd El-Fattah

: In this work, 1,2,4-triazine derivatives were synthesized and evaluated for anticancer activities. Series of 1,2,4-triazine derivatives (4a, b) were prepared via the reaction of N-benzoyl glycine (1) with aromatic aldehydes in presence of fused sodium acetate and acetic anhydride to give 1,3-oxazolinone derivatives (2a, b), followed by condensation with 1-(ethoxycarbonyl) hydrazine (3) in glacial acetic acid. Compounds (4a, b) then reacted with acetic anhydride, ethyl chloroacetate and 2,4-dinitrophenyl hydrazine yielded the corresponding to N-acetyl derivatives (5a, b), N-(ethoxycarbonyl) methyl derivative (6) and 1,2-disubstituted hydrazine (7), respectively. The structures of the 1,2,4-triazine derivatives were confirmed by IR, 1H, 13C NMR, MS and elemental analyses. Anticancer activity of some 1,2,4-triazine derivatives (4-7) have been investigated. The results revealed that compounds 4a (IC50= 2.7μM), 5a (IC50= 1.5μM), and 5b (IC50= 3.9μM) show promising inhibitory growth efficacy compared to a standard antitumor drug (IC50= 4.6μM). These three compounds can be considered as potential agents against human hepatocellular carcinoma cell lines (HepG-2).


1977 ◽  
Vol 55 (5) ◽  
pp. 831-840 ◽  
Author(s):  
Brian Maurice Lynch ◽  
Suresh Chandra Sharma

3-Oxo-s-triazolo[4,3-a]pyridine and various C-methyl derivatives (general structure 1) have been converted into the 2-β-D-ribofuranosyl species 2 and thence 4 via Friedel–Crafts catalyzed reaction with tetra-O-acetyl-β-D-ribofuranose, followed by deblocking. During the course of these reactions, rearrangements into the isomeric 3-β-D-ribofuranosyl-2-oxo-s-triazolo[1,5-a]-pyridines occur through ring-opening of the pyridine rings yielding species 3 and 5. The proportion of rearrangement products is dependent upon the position and number of the C-methyl substituents.Structural assignments for these compounds are based upon comparisons of spectroscopic properties (1H nmr, 13C nmr, uv) with model compounds from each isomeric series; structural assignments for these models are based on unequivocal mass-spectral fragmentation patterns. Unlike related triazolopyridine nucleosides with the ribose moiety attached to a pyridine nitrogen (Lynch and Sharma (1976)), there are no unusual aspects in the conformations of the nueleosides of types 4 and 5.


Sign in / Sign up

Export Citation Format

Share Document